S1 Data - by Xiying Wang (4859998)

“…In contrast, the EGA-BPNN model achieves a significantly lower mean absolute relative error of 0.41% for single-flow prediction, demonstrating superior prediction performance. …”

Algorithm flow of the GA-BPNN model. by Xiying Wang (4859998)

“…In contrast, the EGA-BPNN model achieves a significantly lower mean absolute relative error of 0.41% for single-flow prediction, demonstrating superior prediction performance. …”

Baseline characteristics. by Daniela Sánchez-Santiesteban (21192342)

“…</p><p>Conclusion</p><p>Significant income-based disparities in colorectal cancer survival were observed among formal employees in Colombia despite the theoretically equitable healthcare system. …”

Office characteristics and RW adoption. by Yasuhiko Deguchi (3167955)

Subjects:

Newly occurring LTSA-MD cases in workers for over a month. by Yasuhiko Deguchi (3167955)

Subjects:

Difference in the number of LTSA between FY 2020 and FY 2019. by Yasuhiko Deguchi (3167955)

Subjects:

BMI groups by SES. by Krystal Hunter (6820052)

Subjects:

BMISES_Data_Part2. by Krystal Hunter (6820052)

Subjects:

Logistic regression for LSES population. by Krystal Hunter (6820052)

Subjects:

Logistic regression for HSES population. by Krystal Hunter (6820052)

Subjects:

Logistic regression for overall population. by Krystal Hunter (6820052)

Subjects:

BMISES_Data_Part1. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of HSES/LSES population. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of overall population. by Krystal Hunter (6820052)

Subjects:

Diagram of study population. by Krystal Hunter (6820052)

Subjects:

Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. by Aga E. Gelgie (17661720)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. by Randa Mohammed Zaki (21637175)

Subjects:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. by Randa Mohammed Zaki (21637175)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects: